Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Langsted

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Ugeskrift for Laeger|August 15, 2009
[Fasting and nonfasting lipids--secondary publication]Anne Langsted, Jacob J Freiberg, Børge G Nordestgaard
Atherosclerosis|March 18, 2014
Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular riskAnne Langsted, Pia R Kamstrup, Børge G Nordestgaard
Atherosclerosis|December 31, 2016
Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004-2014Anne Langsted, Jacob J Freiberg, Børge G Nordestgaard
JAMA Internal Medicine|November 8, 2016
Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute PancreatitisSimon B Pedersen, Anne Langsted, Børge G Nordestgaard
Journal of the American College of Cardiology|July 6, 2019
Elevated Lipoprotein(a) and Risk of Ischemic StrokeAnne Langsted, Børge G Nordestgaard, Pia R Kamstrup
European Heart Journal|March 16, 2021
Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population studyAnne Langsted, Børge G Nordestgaard, Pia R Kamstrup
Clinical Chemistry|September 8, 2017
High Lipoprotein(a) and Low Risk of Major Bleeding in Brain and Airways in the General Population: a Mendelian Randomization StudyAnne Langsted, Pia R Kamstrup, Børge G Nordestgaard
Circulation|October 29, 2008
Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk predictionAnne Langsted, Jacob J Freiberg, Børge G Nordestgaard
Current Atherosclerosis Reports|February 4, 2024
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and TreatmentAnders Berg Wulff, Børge G Nordestgaard, Anne Langsted
European Journal of Epidemiology|January 2, 2023
Smoking as the most important risk factor for chronic pancreatitis in the general populationSigne E J Hansen, Børge G Nordestgaard, Anne Langsted
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Ugeskrift for Laeger|August 15, 2009
[Fasting and nonfasting lipids--secondary publication]Anne Langsted, Jacob J Freiberg, Børge G Nordestgaard
Atherosclerosis|March 18, 2014
Lipoprotein(a): fasting and nonfasting levels, inflammation, and cardiovascular riskAnne Langsted, Pia R Kamstrup, Børge G Nordestgaard
Atherosclerosis|December 31, 2016
Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004-2014Anne Langsted, Jacob J Freiberg, Børge G Nordestgaard
JAMA Internal Medicine|November 8, 2016
Nonfasting Mild-to-Moderate Hypertriglyceridemia and Risk of Acute PancreatitisSimon B Pedersen, Anne Langsted, Børge G Nordestgaard
Journal of the American College of Cardiology|July 6, 2019
Elevated Lipoprotein(a) and Risk of Ischemic StrokeAnne Langsted, Børge G Nordestgaard, Pia R Kamstrup
European Heart Journal|March 16, 2021
Low lipoprotein(a) levels and risk of disease in a large, contemporary, general population studyAnne Langsted, Børge G Nordestgaard, Pia R Kamstrup
Clinical Chemistry|September 8, 2017
High Lipoprotein(a) and Low Risk of Major Bleeding in Brain and Airways in the General Population: a Mendelian Randomization StudyAnne Langsted, Pia R Kamstrup, Børge G Nordestgaard
Circulation|October 29, 2008
Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk predictionAnne Langsted, Jacob J Freiberg, Børge G Nordestgaard
Current Atherosclerosis Reports|February 4, 2024
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and TreatmentAnders Berg Wulff, Børge G Nordestgaard, Anne Langsted
European Journal of Epidemiology|January 2, 2023
Smoking as the most important risk factor for chronic pancreatitis in the general populationSigne E J Hansen, Børge G Nordestgaard, Anne Langsted
Pageof 8